» Articles » PMID: 30692200

T Cells Transduce T-cell Receptor Signal Strength by Generating Different Phosphatidylinositols

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2019 Jan 30
PMID 30692200
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

T-cell receptor (TCR) signaling strength is a dominant factor regulating T-cell differentiation, thymic development, and cytokine signaling. The molecular mechanisms by which TCR signal strength is transduced to downstream signaling networks remains ill-defined. Using computational modeling, biochemical assays, and imaging flow cytometry, we found here that TCR signal strength differentially generates phosphatidylinositol species. Weak TCR signals generated elevated phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) and reduced phosphatidylinositol (3,4,5)-trisphosphate (PIP3) levels, whereas strong TCR signals reduced PI(4,5)P2 and elevated PIP3 levels. A proteomics screen revealed that focal adhesion kinase bound PI(4,5)P2, biochemical assays disclosed that focal adhesion kinase is preferentially activated by weak TCR signals and is required for optimal Treg induction, and further biochemical experiments revealed how TCR signaling strength regulates AKT activation. Low PIP3 levels generated by weak TCR signals were sufficient to activate phosphoinositide-dependent kinase-1 to phosphorylate AKT on Thr-308 but insufficient to activate mTOR complex 2 (mTORC2), whereas elevated PIP3 levels generated by a strong TCR signal were required to activate mTORC2 to phosphorylate Ser-473 on AKT. Our results provide support for a model that links TCR signaling to mTORC2 activation via phosphoinositide 3-kinase signaling. Together, the findings in this work establish that T cells measure TCR signal strength by generating different levels of phosphatidylinositol species that engage alternate signaling networks to control cell fate decisions.

Citing Articles

Ndrg3 is a critical regulator of peripheral T cell maturation and homeostasis.

Komorowska J, Grammer C, Balan M, Swann J Sci Adv. 2025; 11(11):eads5143.

PMID: 40073135 PMC: 11900881. DOI: 10.1126/sciadv.ads5143.


The phospholipid kinase PIKFYVE is essential for Th17 differentiation.

Prado D, Cattley R, Sonego A, Sutariya P, Wu S, Lee M J Exp Med. 2024; 222(2).

PMID: 39738812 PMC: 11687391. DOI: 10.1084/jem.20240625.


The mTORC2 signaling network: targets and cross-talks.

Ragupathi A, Kim C, Jacinto E Biochem J. 2024; 481(2):45-91.

PMID: 38270460 PMC: 10903481. DOI: 10.1042/BCJ20220325.


Phosphoinositide acyl chain saturation drives CD8 effector T cell signaling and function.

Edwards-Hicks J, Apostolova P, Buescher J, Maib H, Stanczak M, Corrado M Nat Immunol. 2023; 24(3):516-530.

PMID: 36732424 PMC: 10908374. DOI: 10.1038/s41590-023-01419-y.


Recent insights into the role of Akt in CD4 T-cell activation and differentiation: alternative splicing and beyond.

White T, Jin Y, Gable M, Morel P Immunometabolism (Cobham). 2023; 5(1):e00015.

PMID: 36710922 PMC: 9869951. DOI: 10.1097/IN9.0000000000000015.


References
1.
Malek M, Kielkowska A, Chessa T, Anderson K, Barneda D, Pir P . PTEN Regulates PI(3,4)P Signaling Downstream of Class I PI3K. Mol Cell. 2017; 68(3):566-580.e10. PMC: 5678281. DOI: 10.1016/j.molcel.2017.09.024. View

2.
Gan X, Wang J, Su B, Wu D . Evidence for direct activation of mTORC2 kinase activity by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 2011; 286(13):10998-1002. PMC: 3064154. DOI: 10.1074/jbc.M110.195016. View

3.
Waugh M, Minogue S, Hsuan J . Quantification of multiple phosphatidylinositol 4-kinase isozyme activities in cell extracts. Methods Mol Biol. 2009; 462:279-89. DOI: 10.1007/978-1-60327-115-8_19. View

4.
Lemmon M, Ferguson K, Schlessinger J . PH domains: diverse sequences with a common fold recruit signaling molecules to the cell surface. Cell. 1996; 85(5):621-4. DOI: 10.1016/s0092-8674(00)81022-3. View

5.
Constant S, Pfeiffer C, Woodard A, Pasqualini T, Bottomly K . Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J Exp Med. 1995; 182(5):1591-6. PMC: 2192213. DOI: 10.1084/jem.182.5.1591. View